These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35836882)

  • 21. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.
    Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T
    Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
    Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
    World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma.
    Xu Y; Liao W; Wang T; Zhang L; Zhang H
    Discov Oncol; 2024 Jun; 15(1):246. PubMed ID: 38926181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
    Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
    Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma.
    Liu Y; Li R; Wang X; Xue Z; Yang X; Tang B
    Front Cell Dev Biol; 2022; 10():824938. PubMed ID: 35693941
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of complement in the clinical course of hepatocellular carcinoma.
    Qian X; Yang Z; Gao L; Liu Y; Yan J
    Immun Inflamm Dis; 2022 Mar; 10(3):e569. PubMed ID: 34813686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker.
    Xue C; Gao P; Cui X; Zhang X; Lei J; Li R; Zhu C; Qin X
    Front Oncol; 2021; 11():680070. PubMed ID: 34249720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
    Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
    World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
    Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma.
    Chen YR; Ouyang SS; Chen YL; Li P; Xu HW; Zhu SL
    Aging (Albany NY); 2020 Sep; 12(17):17541-17567. PubMed ID: 32927435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma.
    Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL
    Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Role of NEU1 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis.
    Wu Z; He L; Yang L; Fang X; Peng L
    Front Mol Biosci; 2021; 8():651525. PubMed ID: 34513919
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma.
    Wang Z; Wen P; Hu B; Cao S; Shi X; Guo W; Zhang S
    Cancer Cell Int; 2021 Oct; 21(1):586. PubMed ID: 34717619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma.
    Sang X; Wu F; Wu D; Lin S; Li J; Zhao N; Chen X; Xu A
    Front Genet; 2020; 11():112. PubMed ID: 32184801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Role of MAP3K14 in Hepatocellular Carcinoma: A Study Based on Comprehensive Bioinformatical Analysis and Validation.
    Tang K; Lin W; Wang D; Hu X; Chen Z; Chen J; Liang B; Zhang L; Qin P; Wu D
    J Cancer; 2024; 15(9):2731-2745. PubMed ID: 38577603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Yang S; Ye J; Wei Z; Chu T
    J Clin Transl Hepatol; 2022 Aug; 10(4):627-641. PubMed ID: 36062274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.